Prof Lars Ittner
NHMRC
Australia
Mechanisms and treatment in Alzheimer's disease
NHMRC
538,751
01/01/11
6.0
Alzheimer's disease & other dementias
alzheimer disease | microtubule associated protein (map) | transgenic animals | treatment strategies | alzheimer disease
Currently, over 200,000 Australians are affected by Alzheimer’s disease (AD) or frontotemporal lobar degeneration (FTLD), causing a huge socio-economic damage. To overcome the lack of effective treatments, we need to understand the underlying causes and translate them into therapy. Using state-of-the-art cell culture and genetic mouse models, I will reveal fundamental processes in AD and related dementias, and develop tailored treatments to battle these devastating disorders.